These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 16735376

  • 1. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
    Nijnik A, Ferry H, Lewis G, Rapsomaniki E, Leung JC, Daser A, Lambe T, Goodnow CC, Cornall RJ.
    Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
    [Abstract] [Full Text] [Related]

  • 2. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K, Nakamura A, Sugahara A, Takai T.
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [Abstract] [Full Text] [Related]

  • 3. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 4. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 5. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K, Qu WM, Zhang MC, Fujii H, Furukawa H, Miyazaki T, Iwano M, Saito Y, Nose M, Ono M.
    Scand J Immunol; 2007 Dec 01; 66(6):654-61. PubMed ID: 17983422
    [Abstract] [Full Text] [Related]

  • 6. Responses of B cells from autoimmune mice to IL-5.
    Umland SP, Go NF, Cupp JE, Howard M.
    J Immunol; 1989 Mar 01; 142(5):1528-35. PubMed ID: 2783944
    [Abstract] [Full Text] [Related]

  • 7. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T.
    J Immunol; 2013 Jun 01; 190(11):5436-45. PubMed ID: 23616572
    [Abstract] [Full Text] [Related]

  • 8. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, Akira S, Gotoh Y, Kiyono H, Miyake K.
    Int Immunol; 2008 Jul 01; 20(7):881-91. PubMed ID: 18492657
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF, Roths JB, Holmes KL, Rudikoff E, Morse HC.
    J Immunol; 1984 Aug 01; 133(2):1048-56. PubMed ID: 6610701
    [Abstract] [Full Text] [Related]

  • 10. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K, Hamano T, Kakishita E.
    Ryumachi; 1996 Dec 01; 36(6):844-55. PubMed ID: 9122824
    [Abstract] [Full Text] [Related]

  • 11. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O, Shlomchik MJ.
    J Immunol; 1998 Jan 01; 160(1):51-9. PubMed ID: 9551955
    [Abstract] [Full Text] [Related]

  • 12. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells.
    Rathmell JC, Goodnow CC.
    J Immunol; 1994 Sep 15; 153(6):2831-42. PubMed ID: 8077685
    [Abstract] [Full Text] [Related]

  • 13. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M.
    Eur J Immunol; 2005 May 15; 35(5):1510-20. PubMed ID: 15832294
    [Abstract] [Full Text] [Related]

  • 14. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K, Kozono Y, Waldschmidt TJ, Berthiaume D, Quigg RJ, Baron A, Holers VM.
    J Immunol; 1997 Aug 01; 159(3):1557-69. PubMed ID: 9233655
    [Abstract] [Full Text] [Related]

  • 15. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.
    Roark JH, Kuntz CL, Nguyen KA, Mandik L, Cattermole M, Erikson J.
    J Immunol; 1995 May 01; 154(9):4444-55. PubMed ID: 7722301
    [Abstract] [Full Text] [Related]

  • 16. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H, Adachi M, Suematsu S, Miwa K, Suda T, Yoshida N, Nagata S.
    J Immunol; 1998 Apr 15; 160(8):3805-11. PubMed ID: 9558084
    [Abstract] [Full Text] [Related]

  • 17. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K, Ono S, Murakami S, Takahama Y, Katoh Y, Hamaoka T.
    J Immunol; 1987 Feb 01; 138(3):780-7. PubMed ID: 3543118
    [Abstract] [Full Text] [Related]

  • 18. T cell autoimmunity in Ig transgenic mice.
    Shinde S, Gee R, Santulli-Marotto S, Bockenstedt LK, Clarke SH, Mamula MJ.
    J Immunol; 1999 Jun 15; 162(12):7519-24. PubMed ID: 10358207
    [Abstract] [Full Text] [Related]

  • 19. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN, Sobel ES, MacDonald GC, Cheek RL, Cohen PL, Eisenberg RA.
    J Immunol; 1997 Jul 15; 159(2):1027-35. PubMed ID: 9218626
    [Abstract] [Full Text] [Related]

  • 20. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA, Chan J, Byrne RJ, Bischof RJ, Jaworowski A, Kanagasundaram V.
    J Immunol; 1998 Dec 15; 161(12):6802-11. PubMed ID: 9862711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.